The invention described herein relates to certain pyrimidinedione N-substituted glycine derivatives of formula (I)
which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
[EN] PROLYL HYDROXYLASE INHIBITORS<br/>[FR] INHIBITEURS DE PROLYL HYDROXYLASE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2010025087A1
公开(公告)日:2010-03-04
The invention described herein relates to certain pyrimidinedione N-substituted glycine derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.